HERON THERAPEUTICS INC's ticker is HRTX and the CUSIP is 427746102. A total of 193 filers reported holding HERON THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is 1.77 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,467,394 | +3.5% | 2,395,161 | +16.6% | 0.00% | – |
| Q2 2023 | $2,383,134 | -20.1% | 2,054,426 | +4.0% | 0.00% | – |
| Q1 2023 | $2,982,180 | +60810.5% | 1,974,954 | +0.8% | 0.00% | -100.0% |
| Q4 2022 | $4,896 | -99.9% | 1,958,442 | +7.2% | 0.00% | 0.0% |
| Q3 2022 | $7,706,000 | +52.4% | 1,826,299 | +0.8% | 0.00% | 0.0% |
| Q2 2022 | $5,057,000 | -46.2% | 1,812,634 | +10.2% | 0.00% | 0.0% |
| Q1 2022 | $9,405,000 | -39.8% | 1,644,360 | -3.9% | 0.00% | -50.0% |
| Q4 2021 | $15,626,000 | -9.3% | 1,711,608 | +6.2% | 0.00% | 0.0% |
| Q3 2021 | $17,236,000 | -30.1% | 1,612,375 | +1.4% | 0.00% | -33.3% |
| Q2 2021 | $24,667,000 | +5.6% | 1,589,392 | +10.3% | 0.00% | -25.0% |
| Q1 2021 | $23,360,000 | -15.4% | 1,441,145 | +10.5% | 0.00% | -20.0% |
| Q4 2020 | $27,613,000 | +48.2% | 1,304,671 | +3.8% | 0.01% | +25.0% |
| Q3 2020 | $18,633,000 | -0.1% | 1,257,290 | -0.9% | 0.00% | 0.0% |
| Q2 2020 | $18,655,000 | +31.6% | 1,268,186 | +5.0% | 0.00% | 0.0% |
| Q1 2020 | $14,176,000 | -73.4% | 1,207,511 | -46.7% | 0.00% | -33.3% |
| Q4 2019 | $53,214,000 | +211.9% | 2,264,520 | +145.5% | 0.01% | +50.0% |
| Q3 2019 | $17,061,000 | +2.3% | 922,225 | +2.8% | 0.00% | 0.0% |
| Q2 2019 | $16,676,000 | -16.3% | 897,080 | +10.0% | 0.00% | -20.0% |
| Q1 2019 | $19,924,000 | -48.9% | 815,228 | -45.7% | 0.01% | -16.7% |
| Q4 2018 | $38,974,000 | +69.9% | 1,502,500 | +107.3% | 0.01% | 0.0% |
| Q3 2018 | $22,940,000 | -8.8% | 724,821 | +11.9% | 0.01% | -25.0% |
| Q2 2018 | $25,159,000 | +91.6% | 647,611 | +36.1% | 0.01% | +100.0% |
| Q1 2018 | $13,129,000 | +82.5% | 475,700 | +19.7% | 0.00% | +100.0% |
| Q4 2017 | $7,193,000 | +12.8% | 397,456 | +0.6% | 0.00% | 0.0% |
| Q3 2017 | $6,379,000 | +19.1% | 395,046 | +2.2% | 0.00% | 0.0% |
| Q2 2017 | $5,354,000 | -0.7% | 386,626 | +7.5% | 0.00% | 0.0% |
| Q1 2017 | $5,394,000 | +55.7% | 359,640 | +35.9% | 0.00% | 0.0% |
| Q4 2016 | $3,465,000 | -21.1% | 264,556 | +3.7% | 0.00% | 0.0% |
| Q3 2016 | $4,394,000 | +11.2% | 255,038 | +16.5% | 0.00% | 0.0% |
| Q2 2016 | $3,952,000 | +0.2% | 218,988 | +5.4% | 0.00% | 0.0% |
| Q1 2016 | $3,945,000 | -27.9% | 207,789 | +1.4% | 0.00% | -33.3% |
| Q4 2015 | $5,469,000 | +6.2% | 204,881 | -2.9% | 0.00% | 0.0% |
| Q3 2015 | $5,148,000 | -16.6% | 211,006 | +6.5% | 0.00% | -25.0% |
| Q2 2015 | $6,171,000 | +185.2% | 198,050 | +33.1% | 0.00% | +300.0% |
| Q1 2015 | $2,164,000 | +71.5% | 148,780 | +18.6% | 0.00% | 0.0% |
| Q4 2014 | $1,262,000 | +22.8% | 125,484 | +1.6% | 0.00% | 0.0% |
| Q3 2014 | $1,028,000 | -24.0% | 123,467 | +12.5% | 0.00% | 0.0% |
| Q2 2014 | $1,352,000 | +56.3% | 109,784 | +76.4% | 0.00% | 0.0% |
| Q1 2014 | $865,000 | – | 62,243 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANG KEVIN C | 760 | $783 | 100.00% |
| Velan Capital Investment Management LP | 6,986,744 | $7,196,346 | 5.80% |
| Tejara Capital Ltd | 2,109,681 | $2,172,971 | 1.23% |
| JW Asset Management, LLC | 2,407,418 | $2,479,641 | 1.07% |
| Rubric Capital Management LP | 26,713,503 | $27,514,908 | 1.03% |
| GREAT POINT PARTNERS LLC | 4,737,368 | $4,879,489 | 0.89% |
| Orchard Capital Management, LLC | 2,142,823 | $2,207,108 | 0.82% |
| Clearline Capital LP | 6,149,842 | $6,334,338 | 0.54% |
| CM Management, LLC | 450,000 | $463,500 | 0.49% |
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 327,450 | $337,274 | 0.48% |